Kevin V. Albuquerque, MBBS, M.S., F.R.C.S., DABR

Harold C Simmons Comprehensive Cancer Center, Department of Radiation Oncology, U.T. Southwestern Medical Center, Dallas, Texas, USA

Dr Kevin Albuquerque is currently Professor and Quality Officer at the Department Radiation Oncology, U.T. Southwestern Medical Center, Dallas, Texas, USA. He is the Clinical Lead for Gynecological Radiation Therapy and Brachytherapy. He also holds the Ken Sharma Endowed Professorship in Radiation Oncology at the university.

He received his medical degree(1986) and a Master of Surgery at Bombay University’s Lokmanya Tilak Municipal Medical College in India. He completed training in Surgical oncology and went on to become a senior resident and research fellow in surgical oncology at Tata Memorial Cancer Hospital in Bombay. From there, he continued his Surgical Oncology training in Nottingham ,UK and became a fellow of the Royal College of Surgeons(FRCS) (1996). He then moved to the United States, where he completed, a residency in radiation oncology at S.U.N.Y. University Hospital and obtained his DABR in 2002.Before joining the faculty of UT Southwestern, Dr. Albuquerque was an Associate Professor in Radiation Oncology at Loyola University Medical Center, where he also served as the Clinical Director of the Department of Radiation Oncology and as the Director of Brachytherapy

He has published over 60 peer-reviewed manuscripts and contributed to three book chapters and is currently editing a book on Gynecological Radiation therapy techniques .In addition, he co-chairs the gynecological radiation oncology track of the American Society of Therapeutic Radiology’s Annual Meeting Scientific Committee ( ASTRO) and serves as a reviewer for the Practical Radiation Oncology Journal and associate editor for the International Journal of Radiation Oncology, Biology, Physics. He is also a Core member of the cervix cancer committee for the NRG Oncology research group(USA) . He has been a collaborator on several NIH grants at Loyola University looking at translational effects of breast radiation on immune markers and quality of life for patients undergoing breast conservation therapy including radiation therapy.